-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, HwEWrdDiZ+TraKpgljrWdeQZPfWfg0SUK3gw8BcH/8IUUcQD3dz0JgvASAy5pQsh VqOHOfzAGKQFIvpo5Z+yDw== 0000922423-08-000121.txt : 20080205 0000922423-08-000121.hdr.sgml : 20080205 20080205161621 ACCESSION NUMBER: 0000922423-08-000121 CONFORMED SUBMISSION TYPE: SC 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20080205 DATE AS OF CHANGE: 20080205 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: Chachkes Lawrence CENTRAL INDEX KEY: 0001390040 FILING VALUES: FORM TYPE: SC 13G/A BUSINESS ADDRESS: BUSINESS PHONE: 2127159100 MAIL ADDRESS: STREET 1: C/O KRAMER LEVIN NAFTALIS & FRANKEL LLP STREET 2: 1177 AVENUE OF THE AMERICAS CITY: NEW YORK STATE: X1 ZIP: 10036 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: MACROCHEM CORP CENTRAL INDEX KEY: 0000743884 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 042744744 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-36722 FILM NUMBER: 08576930 BUSINESS ADDRESS: STREET 1: 40 WASHINGTON STREET STREET 2: SUITE 220 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 BUSINESS PHONE: 781-489-7310 MAIL ADDRESS: STREET 1: 40 WASHINGTON STREET STREET 2: SUITE 220 CITY: WELLESLEY HILLS STATE: MA ZIP: 02481 SC 13G/A 1 kl02009.htm SCHEDULE 13G FINAL AMENDMENT kl02009.htm



SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C.  20549
 
                   
 
Under the Securities Exchange Act of 1934
 
SCHEDULE 13G

FINAL AMENDMENT

INFORMATION STATEMENT PURSUANT TO RULES 13d-1 AND 13d-2
 
UNDER THE SECURITIES EXCHANGE ACT OF 1934
 
     MacroChem Corporation.    
(Name of Issuer)
 
         Common Stock, par value $0.01 per share         
(Title of Class of Securities)
 
         555903301         
(CUSIP Number)
 
                        December 31, 2007                      
(Date of Event Which Requires Filing of this Statement)
 
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
 
¨  Rule 13d-1(b)
ý  Rule 13d-1(c)
¨  Rule 13d-1(d)
 
                   
 
Page 1 of 6 Pages



SCHEDULE 13G
 
CUSIP No. 555903301                                                                                    Page 2 of 6 Pages
 
1)
NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Lawrence Chachkes
2)
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP
(a)        o
(b)        o
3)
SEC USE ONLY
4)
CITIZENSHIP OR PLACE OF ORGANIZATION
United States
 
NUMBER
OF
SHARES
BENEFICIALLY
OWNED BY
EACH
REPORTING
PERSON
WITH
5)
SOLE VOTING POWER
89,119*
6)
SHARED VOTING POWER
None
7)
SOLE DISPOSITIVE POWER
89,119*
8)
SHARED DISPOSITIVE POWER
None
9)
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
89,119*
10)
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
o
11)
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
0.4%
12)
TYPE OF REPORTING PERSON
IN
 
* Includes 50,000 shares which are issuable upon exercise of warrants.
 

 


Schedule 13G
 
Item 1(a).
Name of Issuer:
 
MacroChem Corporation.
 
Item 1(b).       Address of Issuer’s Principal Executive Offices:
 
40 Washington Street
Suite 220
Wellesley Hills, MA 02481

Item 2(a).       Name of Person Filing:

Lawrence Chachkes
 
Item 2(b).
Address of Principal Business Office or, if None, Residence:
 
60 East 8th Street
Apt 11M
New York  NY  10003

Item 2(c).
Citizenship:
 
United States
 
Item 2(d).
Title of Class of Securities:
 
Common Stock
 
Item 2(e).
CUSIP Number:
 
555903301
 
Item 3.        If this statement is filed pursuant to §§ 240.13d-1(b), or 240.13d-2(b) or (c), check whether the person filing is a:
 
 
(a)
¨
Broker or Dealer Registered Under Section 15 of the Act (15 U.S.C. 78o)
 
 
(b)
¨
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c)
 
 
(c)
¨
Insurance Company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c)
 
 
(d)
¨
Investment Company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8)
 
 
(e)
¨
Investment Adviser in accordance with § 240.13d-1(b)(1)(ii)(E)
 
 
(f)
¨
Employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F)
 
 

 
 
(g)
¨
Parent Holding Company or control person in accordance with §240.13d-1(b)(ii)(G)
 
 
(h)
¨
Savings Association as defined in §3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813)
 
 
(i)
¨
Church plan that is excluded from the definition of an investment company under §3(c)(15) of the Investment Company Act of 1940 (15 U.S.C. 80a-3)
 
 
(j)
¨
Group, in accordance with §240.13d-1(b)(ii)(J)
 
Item 4.
Ownership.
 
                (a)          Amount beneficially owned: 89,119
 
                (b)          Percent of class1:  0.4%
 
                 (c)         Number of shares as to which such person has:
 
                       (i)      Sole power to vote or to direct the vote: 89,119*
 
                       (ii)     Shared power to vote or to direct the vote: None
 
                       (iii)    Sole power to dispose or to direct the disposition of: 89,119*
 
                       (iv)    Shared power to dispose or to direct the disposition of: None
 
Item 5.
Ownership of Five Percent or Less of a Class.
 
This statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five (5) percent of the class of securities.

Item 6.       Ownership of More than Five Percent on Behalf of Another Person.

The owners of the accounts (including the Profit-Sharing Plan) in which the shares reported on this Schedule are held have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities.

Item 7.           Identification and Classification of the Subsidiary Which Acquired the SecurityBeing Reported on by the Parent Holding Company.

Not applicable


 
1 Percentages are based on 22,461,997 shares of Common Stock outstanding (as set forth in the Issuer’s Form 10-Q filed on November 13, 2007).
 
* Includes 50,000 shares which are issuable upon exercise of warrants.

 



Item 8.        Identification and Classification of Members of the Group.
 
Not applicable
 
Item 9.
Notice of Dissolution of Group.
 
Not applicable
 
Item 10.
Certification.
 
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of such securities and were not acquired and are not held in connection with or as a participant in any transaction having such purposes or effect.
 

 


 
SIGNATURE
 
After reasonable inquiry and to the best knowledge and belief of the undersigned, the undersigned certifies that the information set forth in this Statement is true, complete and correct.
 
                        January 31, 2008                                    
                    Date
 
 
                /s/ Lawrence Chachkes                       
                           Signature
 
                       Lawrence Chachkes                                                                                      
                   Name/Title
 

 
 

 
-----END PRIVACY-ENHANCED MESSAGE-----